Tag Archives: SVA

Top 10 Clean Energy Stocks To Buy Right Now

America’s job market is hotter than Taylor Swift’s new album.

The country has added jobs for 86 consecutive months — the longest streak on record — according to the Labor Department. Its numbers date back to 1939.

The unemployment rate has ticked down to 4.1%, the lowest level since 2000. Compare that to 10%, which it reached in October 2009, when the economy was in shambles. Experts say that the current low rate shows it won’t get much better than this.

“The overwhelming evidence from the labor market is that the economy is, in fact, at full employment,” says David Kelly, chief global strategist at JPMorgan Funds.

Americans seem to be shedding some recession scars. Consumer confidence is near its highest level in 17 years, fueled by a strong job market and the Republicans’ long-anticipated tax reform plan, which was signed into law last week.

And jobless claims have reached their lowest level this year since 1973. The labor force was much smaller back then.

Top 10 Clean Energy Stocks To Buy Right Now: Forward Pharma A/S(FWP)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of theDanish drugmaker Forward Pharma A/S (NASDAQ:FWP) gained 48.2% yesterday as the result of a settlement and licensing deal with Biogen (NASDAQ:BIIB)involving an ongoing patent dispute over the multiple sclerosis drug Tecfidera. Per the terms of the deal, Biogen will fork overa non-refundable$1.25 billion licensing fee, and possibly pay 10% to 20% royalties on Tecfidera’snet sales to Forward starting in 2021.

  • [By Jim Robertson]

    Last Friday, our Under the Radar Moversnewsletter suggested going long on small cap clinical-stage biopharmaceutical stock Forward Pharma A/S (NASDAQ: FWP):

Top 10 Clean Energy Stocks To Buy Right Now: Silicon Graphics International Corp(SGI)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Cray Incstill and by far outperforming other supercomputer players likelarge caps International Business Machines Corp (NYSE: IBM) andHewlett-Packard Company (NYSE: HPQ) plus small cap Silicon Graphics International Corp (NASDAQ: SGI):

Top 10 Clean Energy Stocks To Buy Right Now: EQT GP Holdings, LP(EQGP)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Not only does Jana consider the deal price overvalued, but it looks to redirect EQT’s focus to a breakup of pipeline operations to transform the core company into an exploration & production firm. The pipelines already trade publicly under EQT Midstream Partners LP (NYSE: EQM) and EQT GP Holdings LP (NYSE: EQGP).

Top 10 Clean Energy Stocks To Buy Right Now: Liberty Broadband Corporation(LBRDK)

Advisors’ Opinion:

  • [By Andrew Tonner]

    After focusing on his philanthropic activities for a number of years, Soros resumed a more active role at his eponymous Soros Fund Management in mid-2016.Around the same time,the famed investor loaded up on shares of Liberty Broadband (NASDAQ:LBRDK) (NASDAQ:LBRDA), and the roughly $615 million stake he owns in the company represented his largest holding in his latest quarterly filing — and for good reason.

Top 10 Clean Energy Stocks To Buy Right Now: Yanzhou Coal Mining Company Limited(YZC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday afternoon, energy shares slipped by just 0.1 percent. Meanwhile, top gainers in the sector included Superior Energy Services, Inc. (NYSE: SPN), and Yanzhou Coal Mining Co Ltd (ADR) (NYSE: YZC).

Top 10 Clean Energy Stocks To Buy Right Now: Heartware International, Inc.(HTWR)

Advisors’ Opinion:

  • [By Spencer Israel]

    4. HeartWare International Inc (NASDAQ: HTWR) – The heart device maker agreed to be acquired by Medtronic for $58 per share in cash two weeks ago. Prior to that the stock had been trading just above $30. 

Top 10 Clean Energy Stocks To Buy Right Now: Superior Energy Services Inc.(SPN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday afternoon, the energy shares slipped by just 0.2 percent. Meanwhile, top gainers in the sector included Willbros Group Inc (NYSE: WG), up 7 percent, and Superior Energy Services, Inc. (NYSE: SPN), up 6 percent.

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Friday. Top gainers in the sector included Superior Energy Services, Inc. (NYSE: SPN), Panhandle Oil and Gas Inc. (NYSE: PHX), and SM Energy Co (NYSE: SM).

  • [By Wayne Duggan]

    Instead, Genargo prefers oil services stocks with the most exposure to the U.S market. Loop names Halliburton Company (NYSE: HAL) as its top large-cap stock pick and Oil States International, Inc. (NYSE: OIS), Newpark Resources Inc (NYSE: NR) and Superior Energy Services, Inc. (NYSE: SPN) as its top small- and mid-cap stocks.

  • [By Lisa Levin]

    Thursday afternoon, energy shares slipped by just 0.1 percent. Meanwhile, top gainers in the sector included Superior Energy Services, Inc. (NYSE: SPN), and Yanzhou Coal Mining Co Ltd (ADR) (NYSE: YZC).

Top 10 Clean Energy Stocks To Buy Right Now: Cameco Corporation(CCJ)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, the Athabasca Basin is home to the McArthur River Uranium Mine -the worlds largest high-grade uranium deposit(accounting for 13% of world mine production) operated by mid cap uranium producer Cameco Corp (NYSE: CCJ).

  • [By Jim Robertson]

    Uranium was first discovered in the region in the 1940s with the first mine being the Rabbit Lake Mine which was discovered in 1968 by Gulf Mineral Resources and opened in 1975. The most important current mineisCameco Corps (NYSE: CCJ) McArthur River mine which isthe world’s largest high-grade uranium mine producing some 13% of global uranium production. Other important Athabasca Basin uranium mines include the Cigar Lake Mine, the Cluff Lake mine (now closed), the Key Lake mine and the McClean Lake mine plus the region continues to be an important center for uranium exploration for good reason as the following infographic illustrates:

Top 10 Clean Energy Stocks To Buy Right Now: Lennar Corp.(LEN)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    We initiated Lennar (NYSE:LEN) in October, and thus wrote up our comments in our prior shareholder letter, but due to the shift in our letter cadence, we are republishing our thoughts from our initial purchase.

    Marty Whitman said in October 1996: “Given Third Avenue’s investment criteria, it is more accurate to view the situation as the industry selecting the Fund, rather than Third Avenue choosing the industries in which to invest’ We think this quote superbly describes the opportunity the Value Fund saw in establishing a position in Lennar Corporation common in the quarter, as the shares sold off somewhat inexplicably from nearly $50 per share at their recent peak and allowed us to establish a position at just over $41.

    We have followed Lennar for years as the Real Estate team reviewed the position at our weekly research meetings, and think the investment case has only improved on a fundamental level despite the widening valuation discount in the shares. Lennar meets every tenant of our investment philosophy.

    The balance sheet is strong and improving. Homebuilding net debt to total capital has fallen to 33% as of FY4Q16. Much of this improvement is the result of management’s soft pivot land strategy, which is reducing the duration of its owned land bank and converting its undervalued balance sheet assets into cash.

    From a compounding point of view, Lennar continues to build value through developing its land bank into saleable housing units, and by monetizing further transaction values through its mortgage origination and title insurance offerings to its home buyers. Notably, we are pleased and supportive of Lennar’s offer to acquire WCIC Communities (WCIC), a top holding of the Third Avenue Small-Cap Value Fund, as Miami-based Lennar knows WCIC’s 100% based Florida assets intimately. Lennar not only sees compelling opportunities to monetize WCIC’s over 14,000 homesites, but also synergy opportunities from management and supplier over

  • [By Lisa Levin]

    Lennar Corp (NYSE: LEN) announced plans to buy CalAtlantic Group Inc (NYSE: CAA) for around $9.3 billion in a stock-and-cash deal, including $3.6 billion in debt.

  • [By Lisa Levin]

    Breaking news

    Lennar Corporation (NYSE: LEN) reported better-than-expected profit for its first quarter on Tuesday.
    General Mills, Inc. (NYSE: GIS) reported upbeat earnings for its fiscal third quarter, while sales missed estimates.
    Genesis Energy, L.P. (NYSE: GEL) disclosed that it has priced its public offering of 4 million common units for gross proceeds of $124 million.
    South State Corporation (NASDAQ: SSB) reported that it has increased its buyback plan from 250,000 shares to 1 million shares.

  • [By Todd Shriber, ETF Professor]

    The index NAIL tries to deliver triple the daily returns of is top heavy. D.R. Horton Inc. (NYSE: DHI), Lennar Corp. (NYSE: LEN), NVR Inc. (NYSE: NVR), Pulte Group Inc. (NYSE: PHM), Toll Brothers Inc. (NYSE: TOL) and Home Depot Inc. (NYSE: HD) account for a significant portion of the benchmark's weight.

  • [By Peter Graham]

    A long term performance chart shows KB Home along with large cap D.R. Horton, Inc (NYSE: DHI) and mid capsLennar Corporation (NYSE: LEN) and PulteGroup, Inc (NYSE: PHM) somewhat range bound or volatile for the past four years:

Top 10 Clean Energy Stocks To Buy Right Now: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

Top 5 Medical Stocks For 2018

Xbiotech’s potential upside vs. downside

Xbiotech (NASDAQ:XBIT) has presented the abstract of its European Phase III trial of Xilonix to treat patients with metastatic colorectal cancer (mCRC) refractory to standard treatment at the ESMO GI (European Society for Medical Oncology) 2016, early July. The abstract has shown a 76% relative increase in clinical response rate (CRR), associated with a 2.7-fold increase in median overall survival (11.5 vs. 4.2 months responders vs. non-responders), an increase in Lean Body Mass (LBM) and an improved Quality of Life (QoL) with little safety concerns, all surrogate parameters for anti-cancer activity and prolonged survival – see ESMO Press release and my previous SA article.

This abstract came under scrutiny by the discussant, an executive member of the ESMO, at the same conference, questioning whether those results “is any benefit in translating this trial into practice.” – press release ESMO .

Others, like Adam Feuerstein, right away played on the above criticism, taking down Xbiotech’s results – see here, here. In my opinion I still do not have an explanation on how Adam Feuerstein was able to tweet about the OS data before those were presented, other than receiving it from an insider. His tweet was made one day before the scheduled presentation that the Congress – see agenda to compare. In addition, neither on the presentation slide nor on the press release of the discussant issued by ESMO was a declaration of conflict of interest. It goes without saying that the discussant- obviously together with another colleague and executive director of ESMO – are biased towards Xbiotech and Xilonix. Both were prominent figures in clinical trials of Regorafenib and Lonsurf (trifluridine/tipiracil), currently the only two drugs approved for last-line treatment in mCRC refractory to standard therapy. In my opinion such a bias should have been declared. Furthermore, the discussant held several positions with big pharmaceuticals, including Regorafenib’s Bayer AG (OTCPK:BAYZF, OTCPK:BAYRY)- see CME information from Medscape.

Top 5 Medical Stocks For 2018: MINDBODY, Inc.(MB)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q3 2016 earnings report for small cap online wellness services stock MINDBODY Inc (NASDAQ: MB) is scheduled for after the market closes onWednesday (October 26th). MINDBODY Inc along withmid cap fitnessdevice stockFitbit Inc (NYSE: FIT) and small cap fitness center operator Planet Fitness Inc (NYSE: PLNT)allhad IPOsin the summer of 2015 raisingtalk of a fitness stock bubble brewing.

  • [By Joe Tenebruso]

    Mindbody (NASDAQ:MB) provides cloud-based software solutions to the health and wellness industry: Think spas, yoga studios, and fitness classes. It’s a massive market that’s gone largely underserved — and Mindbody is working to address that need.

  • [By Peter Graham]

    Small cap online wellness services stock MINDBODY Inc (NASDAQ: MB) reportedQ2 2017 earnings after the market closed Wednesday with results beating expectations. Total revenue was up 31% to $44.1 million as subscription and services revenue rose 29% to $26.0 million and payments revenue rose 37% to $17.6 million. End of period subscribers increased 6% year over year to 59,345, end of period High Value Subscribers increased 13% year over year, average monthly revenue per subscriber (ARPS) grew 21% year over year to approximately $244 and payments volume increased 22% year over year to over $1.9 billion. The GAAP net losswas $4.4 million versus a GAAP net loss of $6.6 million. Rick Stollmeyer, Co-founder and CEO of MINDBODY, commented:

  • [By Peter Graham]

    A long term performance chart shows Fitbit initially surging after its IPO before loosing most of its value while large capGarmin Ltd (NASDAQ: GRMN) (which hasa fitness segment)has been range bound for over a year and small cap online wellness services stockMINDBODY Inc (NASDAQ: MB) has taken off with performance starting to moderate:

  • [By Peter Graham]

    A long term performance chart shows Fitbit Inc initially surging after its IPO before loosing most of its value while large capGarmin Ltd (NASDAQ: GRMN) (which hasa fitness segment)has moved back and forth from positive to negative territory and small cap online wellness services stockMINDBODY Inc (NASDAQ: MB) has taken off for the past year:

Top 5 Medical Stocks For 2018: Devon Energy Corporation(DVN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Beta Should Lead At The Start of A Rally: Best ideas in the first leg up: Marathon Oil, Devon Energy (DVN), Anadarko Petroleum (APC), and Continental Resources (CLR). If OPEC announces a cut, whether moderate or deep, we expect that in the initial move up, moderate value beta names, like Marathon Oil, Devon Energy, Anadarko Petroleum, andContinental Resources will lead.For a $5 increase in oil prices, we estimate 2017 cash flow per share would increase 12-18% for these stocks vs. the remainder of the group at 12%. Of these four, short interest is modest for all exceptContinental Resources at 25%, among the highest in our universe. Outperformance of these names should be driven by investors adding to long positions, not short covering.

  • [By Matthew DiLallo]

    While crude prices stumbled into 2016, they found their footing by mid-year and roared back to life, ending the year up about 42%. Those rising prices lifted most oil stocks. However, a handful of large-cap oil stocks rose above the crowd by outperforming crude’s rally. Those top-tier performers wereContinental Resources (NYSE:CLR), Devon Energy (NYSE:DVN), Anadarko Petroleum (NYSE:APC), Pioneer Natural Resources (NYSE:PXD), and Cimarex Energy (NYSE:XEC):

  • [By Ben Levisohn]

    It wasn’t just Marathon that got clipped as the eight worst-performing stocks in the S&P 500 came from the energy sector, including Murphy Oil (MUR), which fell 6.7% to $25.87, Devon Energy (DVN), which slid 6.5% to $40.72, and Chesapeake Energy (CHK), which stumbled 6.1% to $4.94. No surprise, then, that the Energy Select Sector SPDR ETF (XLE) slumped 2.6% to $69.65.

  • [By Matthew DiLallo]

    U.S. producers hit their peak more than a year ago with production steadily coming down since then due to under-investment. However, the industry has recently started ramping activity back up in an attempt to push back against the natural production decline. For example, leading U.S. driller Devon Energy (NYSE:DVN) reduced its rig count from 40 in early 2015 to five by the third quarter of 2016. As a result, Devon Energy’s third-quarter production from retained assets declined 6.9% year over year. However, Devon Energy has started adding back rigs now that oil prices have stabilized above $50 per barrel and it expected to end 2016 running 10 rigs, with plans to run 15 to 20 by the end of this year. These rigs should push its production up by a low- to mid-single-digitrate this year.

  • [By Matthew DiLallo]

    The failure of Russia and others to fulfill their obligations are coming at a time when U.S. shale production is starting to ramp back up. Shale producers such as Pioneer Natural Resources (NYSE:PXD) and Devon Energy (NYSE:DVN) have already released growth-focused budgets to capture the benefits of an improving oil market. In Pioneer Natural Resources’ case, it expects to spend $2.8 billion this year to operate 18 drilling rigs in the Permian Basin and restart its drilling program in the Eagle Ford. Those rigs should enable the company to drill enough wells to grow its production by 15% to 18% over last year’s average. Meanwhile, Devon Energy expects to spend between $2 billion to $2.3 billion on drilling this year, which should fuel 13% to 17% oil production growth by the fourth quarter versus last year’s final quarter.

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian said traders were buying calls in Devon Energy Corp (NYSE: DVN) in the first half of the trading session on Thursday.

Top 5 Medical Stocks For 2018: Corbus Pharmaceuticals Holdings, Inc.(CRBP)

Advisors’ Opinion:

  • [By Sean Williams]

    This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.

    GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%

    As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!

  • [By Keith Speights]

    Corbus Pharmaceuticals (NASDAQ:CRBP) managed to become one of the top-performing biotech stocks on the market in 2016. Over the last 12 months, Corbus’ share price has soared 550%.

Top 5 Medical Stocks For 2018: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

Top 5 Medical Stocks For 2018: C.H. Robinson Worldwide, Inc.(CHRW)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) were down 4 percent to $71.69. UBS downgraded C.H. Robinson Worldwide from Neutral to Sell.

  • [By Gary Jakacky]

    Only one company convincingly jumped thru all the hoops: C.H. Robinson Worldwide, Inc. (CHRW).

    If only one of the companies in IYT appear to be undervalued, it might give you pause about how brightly the ETF will shine in the very near future.

  • [By Chad Tracy]

    As it's known today, C.H. Robinson (Nasdaq: CHRW) has again changed with the times.

    Unlike transportation industry titans FedEx (NYSE: FDX) or UPS (NYSE: UPS), C.H. Robinson does not own a fleet of trucks that transport goods. Instead, it specializes in logistics. Other companies hire C.H. Robinson to make their transportation services more efficient.

stock market us

2017 has become the year bitcoin went big.

It started the year worth less than $1,000 but has soared more than 1,300% to around $14,000. Back in 2011, it was worth less than a dollar.

Some leading economists and financiers are calling bitcoin a bubble and a fraud, but industry insiders say they think it’s only going to get bigger as it gains more widespread acceptance.

So how does the virtual digital currency work — and what’s behind its spectacular rise?

What is bitcoin?

Bitcoin (XBT) was created in 2009 by an unknown person using the pseudonym Satoshi Nakamoto. Many of its backers saw it as a simple global payment system for anyone to use rather than a financial asset for investors to trade.

Unlike the U.S. dollar or Japanese yen, digital currencies such as bitcoin aren’t issued by central banks like the Federal Reserve. Instead, they are “mined” by computers using complex algorithms.

Payments in bitcoin can be made without traditional middlemen such as banks and without the need to give your name.

stock market us: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

stock market us: Prima BioMed Ltd(PBMD)

Advisors’ Opinion:

  • [By Monica Gerson]

    Prima Biomed (NASDAQ: PBMD) dropped 38.17% to $1.45 after the company reported top-line analysis of CVac Phase 2 trial.

    Tower Group International (NASDAQ: TWGP) plummeted 24.31% to $10.49. Tower Group announced its plans to release its Q2 results during the week of October 7, 2013. FBR Capital downgraded the stock from Outperform to Market Perform.

  • [By Monica Gerson]

    Prima Biomed (NASDAQ: PBMD) shares dipped 38.59% to touch a new 52-week low of $1.44 after the company reported top-line analysis of CVac Phase 2 trial.

stock market us: Chipotle Mexican Grill Inc.(CMG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Chipotle Mexican Grill (CMG) soared to the top of the S&P 500 today after M Science, a data analytics firm, predicted better same-store sales.

    Getty Images

    Chipotle Mexican Grillgained 2.8% to $407.52 today, while the S&P 500 dropped 1.2% to 2,344.02.

    Bloomberg’s Craig Giammona and Leslie Patton have the details on the M Science report:

    Chipotle Mexican Grill Inc. shares rose the most in almost six weeks after data-analysis firm M Science predicted that first-quarter sales will easily beat Wall Streets estimates, bringing a ray of optimism to a chain battered by a food-safety crisis.

    The researcher studied same-store sales during February and the first 10 days of March, according to M Science Chief Executive Officer Michael Marrale. The firm made the call based on multiple data sets and proprietary models, he said.

    Chipotle Mexican Grill’s market capitalization rose to $12.9 billion today from $11.4 billion yesterday. It reported net income of $22.9 million on sales of $3.9 billion in 2016.

  • [By Mike Turner]

    Turner pick Chipotle Mexican Grill(CMG) as his entry into the Best Stocks competition. Chipotle certainly has been one of the best stocks to buy in years past; CMG stock has earned a return of 930% in the past decade, beating the S&P 500’s 105% return by more than a little bit.

    Brushing off the recent supply problems that resulted in dozens of customers getting sick from E. coli, Turner believes the stock can return to the $700 range when the business recovers from its current rough patch. 

  • [By Dan Caplinger, Tim Brugger, and Seth McNew]

    Risk is always a factor for stock market investors, but if you want the top stocks in your portfolio, you have to be bold. To give you some ideas on which stocks to look at, three Motley Fool contributors weighed in on companies they’re familiar with and made a case for why they deserve a closer look. Read on to learn more about Shopify (NYSE:SHOP), Chipotle Mexican Grill (NYSE:CMG), and Universal Display (NASDAQ:OLED) and why they deserve your attention.

stock market us: Williams Partners L.P.(WPZ)

Advisors’ Opinion:

  • [By Ben Levisohn]

    In a release after the close on Monday, Williams and Williams Partners (WPZ) made several announcements, including: 1) outlining managements plan to financially reposition and simplify the franchises GP/LP structure in an ~$11.4 billion transaction (not subject to any additional approvals), 2) adjustments to Williams and Williams Partners’ dividend and distribution payouts, 3) initiating a ~$2+ billion William equity raise to fund a further Williams investment in Williams Partners, 4) noted other potential upcoming changes, including the sale of ~$2 billion in non-core assets in 2017, and 5) provided several forms of updated 2017 guidance…

stock market us: Ishares Trust Dj Us Financial (IYF)

Advisors’ Opinion:

  • [By Wayne Duggan]

    Investors looking to set up a pair trade to capitalize on the divergent paths of U.S. and European banks should consider going long the iShares Dow Jones US Financial (ETF) (NYSE: IYF) and short the Ishares MSCI Europe Fincls Sctr Indx Fd (NASDAQ: EUFN).

invest financial

(Photo by David Ryder/Getty Images)

The Amazon-Whole Foods deal will have winners and losers. Among the winners will be consumers, as Amazon’s technology and superior services will provide more grocery options, saving them time and money at the same time.

Among the losers will be traditional neighborhood stores, which won’t be able to compete with Amazon’s razor thin operating margins – and minimum wage employees like cashiers, as Amazon’s technology will make them dispensable and speed  up a trend already underway in traditional retail chains…and in the process, make the $15 minimum wage irrelevant.

While it’s still unclear how Amazon will re-organize Whole Foods, a video released on Amazon Go stores last year may provide a good hint—there will be no cashiers. They will all be replaced by technology, which monitors customers entering the store, records what they buy, and ensures that they are charged the appropriate amount. Though Amazon officials are denying the company has such plans for Whole Foods. “Amazon has no plans to use the technology it developed for Amazon Go to automate the jobs of cashiers at Whole Foods,” said, a spokesman for Amazon. “No job reductions are planned as a result of the deal” he said.

invest financial: Nemaska Lithium Inc. (NMKEF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Nemaska Lithium (OTCQX:NMKEF) has successfully commissioned the electrolysis cell of its Phase 1 plant in Shawinigan. More heavy lifting will be necessary before the lithium miner will be able to report successful processing of ore from its Whabouchi mine, but boxes are certainly ticked by this company.

  • [By SEEKINGALPHA.COM]

    Nemaska Lithium (OTCQX:NMKEF) provided a project update and announced a C$50 million bought deal with shares selling for C$1.05 a piece. The fresh funds will be put to work at the Whabouchi development project, which appears to be progressing well. Commercial-scale production is expected by Q1 2019.

  • [By SEEKINGALPHA.COM]

    Joe is a fan of Australian-listed Galaxy Resources (GXY on the ASX), acompany with a hard-rock operation in production in Australia, a world-class brine development project (Sal de Vida) in Argentina that has a bank feasibility study on it, and a promising exploration project in Quebec, Canada, near Nemaska’s (OTCQX:NMKEF) Whabouchi project. GXY is up 60% in just the past three months.

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

invest financial: Internet Initiative Japan Inc.(IIJI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, telecommunications services shares fell by 0.29 percent. Meanwhile, top losers in the sector included Telecom Italia SpA (ADR) (NYSE: TI), down 4 percent, and Internet Initiative Japan Inc. (ADR) (NASDAQ: IIJI), down 3 percent.

  • [By Lisa Levin]

    In trading on Thursday, telecommunications services shares fell 0.29 percent. Meanwhile, top losers in the sector included China Unicom (Hong Kong) Limited (ADR) (NYSE: CHU), down 6 percent, and Internet Initiative Japan Inc. (ADR) (NASDAQ: IIJI), down 2 percent.

  • [By Lisa Levin]

    In trading on Wednesday, telecommunications services shares rose by just 0.03 percent. Meanwhile, top losers in the sector included Internet Initiative Japan Inc. (ADR) (NASDAQ: IIJI), down 4 percent, and DigitalGlobe Inc (NYSE: DGI), down 2 percent.

invest financial: JinkoSolar Holding Company Limited(JKS)

Advisors’ Opinion:

  • [By Paul Ausick]

    It is not often that a secondary stock offering sends a companys shares higher, but we are seeing that very phenomenon Friday morning. Chinese solar PV maker JinkoSolar Holding Co. Ltd. (NYSE: JKS) and stock image company Shutterstock Inc. (NASDAQ: SSTK) both priced secondary offerings this morning and shares in both companies have risen sharply.

  • [By Lisa Levin]

    JinkoSolar Holding Co (NYSE: JKS) dropped 9.88% to $16.87 after the company announced the offering of 3,500,000 American Depositary Shares.

    Fuwei Films (Holdings) Co (NASDAQ: FFHL) dropped 9.66% to $1.30. Fuwei Films’ trailing-twelve-month ROE is -10.85%.

  • [By Lisa Levin]

    In trading on Monday, energy shares fell by 0.59 percent. Meanwhile, top losers in the sector included JinkoSolar Holding Co., Ltd. (NYSE: JKS), down 8 percent, and Teekay Offshore Partners L.P. (NYSE: TOO) down 7 percent.

  • [By Paul Ausick]

    But the real news is the near vertical trajectory in share prices for the two stocks. This could be another manifestation of the markets hunger for some momentum plays, as we noted earlier this morning the bump to share prices for both JinkoSolar Holding Co. Ltd. (NYSE: JKS) and Shutterstock Inc. (NASDAQ: SSTK), both of which held secondary share sales this morning.

  • [By Elizabeth Balboa]

    First Solar, Inc (NASDAQ: FSLR) was trading down 3.7 percent Monday, while JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) was down 0.8 percent, SunPower Corporation (NASDAQ: SPWR) 4.4 percent, Canadian Solar Inc. (NASDAQ: CSIQ) 5.2 percent and JinkoSolar Holding Co., Ltd. (NYSE: JKS) 4.4 percent.

invest financial: Barnes Group, Inc.(B)

Advisors’ Opinion:

  • [By Dave and Donald Moenning]

    For those investors that like the comfort generally provided by a diversified portfolio, here’s an idea that will allow you to (a) maintain a diversified allocation in your portfolio and (b) stay out of trouble when the big, bad bears come to call on an asset class or two.

invest financial: Tanger Factory Outlet Centers Inc.(SKT)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Palo Alto Networks (PANW) , Cisco Systems (CSCO) , Tanger Factory Outlet Centers (SKT) and Consolidated Edison (ED) .

  • [By Shauna O’Brien]

    Jefferies announced on Wednesday that it has cut its rating on Tanger Factory Outlet Centers Inc. (SKT).

    The firm has downgraded SKT from “Buy” to “Hold,” and has lowered the company’s price target from $40 to $35. This price target suggests an 8% upside from the stock’s current price of $32.22.

    Analyst Omotayo Okusanya commented: “We expect near-term headwinds for the mall and outlet mall segment as tenant sales growth appears to be slowing.”

    “At SKT, development yields on two projects have also been reduced. Further, rising interest rates negatively impact our DDM-derived PT. Our lowered PT of $35 represents a 10% total return over the next-twelve-months (NTM); we are downgrading to Hold,” added the analyst.

    Tanger Factory Outlet shares were mostly flat during pre-market trading Wednesday. The stock is up more than 5% YTD.

invest financial: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

small stocks

DOL Officially Delays Start of Fiduciary Rule

10 Worst States for Depression Among the College Educated

12 Best Small Cities for Successful Aging: 2017

Fiduciary law expert Ron Rhoades has a question about the core of the Department of Labor’s fiduciary standard rule as it relates to individual retirement accounts: “Is it an angry lion with teeth, or an angry lion without teeth?”

In an interview with ThinkAdvisor, Rhoades, a leading proponent of the rule, bluntly addresses his own question about this “gray area” and the rule as a whole. Rhoades’ expectation: The rule will emerge diluted and, overall, light on enforcement. [This interview with Rhoades took place Nov. 17, before the DOL officially announced on Nov. 27 the 18-month delay in the enforcement provisions of its fiducairy rule.]

Assistant finance professor at Alfred State, Rhoades is a longtime lobbyist on Capitol Hill concerning financial planner and investment advisor issues. Fresh from meetings in Washington with the DOL and Securities and Exchange Commission about fiduciary issues, he anticipates the OMB to publish the rule in about a week.

small stocks: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

small stocks: Core Laboratories N.V.(CLB)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Core Laboratories (NYSE:CLB) literally has its ear to the ground when it comes to deciphering what’s going on in the oil market. The company studies oil reservoirs, which tell it what’s happening with production, giving it a deep level of understanding on the supply side of the market. Core Labs takes what the reservoirs are saying, compares this with other data, and then blends it into an informed macro view of the oil market, which CEO David Demshur shared on the company’s recent quarterly earnings conference call. Here are five things he says the reservoirs are telling us about what’s really going on in the oil market.

  • [By Craig Jones]

    Core Laboratories N.V. (NYSE: CLB) performed poorly and it is in the oil business. Cramer wouldn’t buy it, because he doesn’t want to recommend a stock in the oil and gas business.

  • [By Lisa Levin] Gainers
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter.
    Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
    Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
    Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results.
    Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday
    Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
    AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday.
    Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share.
    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday.
    Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday.
    Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

small stocks: Infinera Corporation(INFN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Infinera Corp. (NASDAQ: INFN) shares were also up, gaining 27 percent to $11.92 after the company reported stronger-than-expected Q4 results.

    Equities Trading DOWN

  • [By Tracey Ryniec]

    Infinera isn’t in a glamorous part of the technology business, as it provides fiber optic connection gear, but as companies like Amazon and Facebook need and use ever more data, it’s Infinera which paves the way. Earnings are expected to grow 31% in 2016. 

  • [By Brian Feroldi]

    Investing in the tech sector can be tricky. Competition tends to be fierce, which makes it difficult to stay one step ahead. Two companies that have a strong history of maintaining their edge are Skyworks Solutions(NASDAQ:SWKS)and Infinera(NASDAQ:INFN). Both of these businesses have been taking market share in their industries for years, which is impressive. But which of these two tech companies is the better investment today? Let’s review the bull thesis for each company so we can make an informed decision.

  • [By Billy Duberstein]

    What a year 2016 was for Infinera (NASDAQ:INFN) shareholders. The stock plunged over 50% last year, as its multiyear run of accelerating 20%-30% growth rates ground to a halt. The story changed from that of a high-growth technology company riding the secular trend of exploding data and bandwidth needs to one of stagnating revenues, profits turning to losses, increased competition, and end customers pausing investments in optical networks.

small stocks: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

small stocks: C.H. Robinson Worldwide, Inc.(CHRW)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) were down 4 percent to $71.69. UBS downgraded C.H. Robinson Worldwide from Neutral to Sell.

  • [By Chad Tracy]

    As it's known today, C.H. Robinson (Nasdaq: CHRW) has again changed with the times.

    Unlike transportation industry titans FedEx (NYSE: FDX) or UPS (NYSE: UPS), C.H. Robinson does not own a fleet of trucks that transport goods. Instead, it specializes in logistics. Other companies hire C.H. Robinson to make their transportation services more efficient.

  • [By Gary Jakacky]

    Only one company convincingly jumped thru all the hoops: C.H. Robinson Worldwide, Inc. (CHRW).

    If only one of the companies in IYT appear to be undervalued, it might give you pause about how brightly the ETF will shine in the very near future.

stock market information

Corrections & Clarifications: Corrects the spelling of Pippin Mader’s name and title

Just weeks after President Trump signaled he’s ready to roll back tough federal vehicle fuel standards, California’s clean-air authority on Friday affirmed that it won’t budge on its own tough standards.

The California Air Resources Board on Friday reaffirmed its own set of regulatory standards for the automotive industry, setting it and 12 other mostly East and West Coast states that are likely to follow its lead on a different path than the rest of the nation.

The 16-member board of California regulators voted unanimously to reaffirm its existing standards for model years 2022 to 2025 for zero emission vehicle sales and greenhouse gas emissions in California despite pleas from the industry for changes.

stock market information: Quality Systems, Inc.(QSII)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Elite Opportunity Pronewsletter suggested small cap health care technology stock Quality Systems, Inc (NASDAQ: QSII) as a short-term trading opportunity after popping sharply on news:

stock market information: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

stock market information: Intrexon Corporation(XON)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Intrexon (XON) has made a small yet strategic acquisition in buying GenVec (GNVC); with the purchase, XON gets AdenoVerse, a platform of adenovirus vectors for delivering drugs and vaccines that dovetails nicely with its existing suite of gene therapy technologies, suggests John McCamant, editor of The Medical Technology Stock Letter.

stock market information: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    As GILD continues to look for further growth drivers beyond HIV and HCV, investor focus unsurprisingly centers on future BD (optionality remains strong with $25B in cash at 3Q15). In the meantime, HCV has turned into a mammoth cash cow allowing GILD to generate ~$15.5B in FCF over the first 9 months of 2015. With ~$11B remaining in its current share repo plan paired with a $0.43/share dividend, we expect GILD to continue returning cash to shareholders. 

  • [By Jack Foley]

    Up to now, I have been very vocal with respect to my bullish opinion regarding Gilead Sciences (NSDQ:GILD). Many investors and analysts alike have been trying to pick a bottom in the stock this year, but the stock stubbornly continues to trade below $75 a share. Worrying downward trends with respect to the company’s HCVdivision remain the dominant theme among investors. Gilead’s HCV division slipped by a whopping 31% last quarter, which resulted in HCV sales of $3.3 billion, which was well below expectation. The stock is now down almost 40% from its high back in June 2015. At present, investors simply can’t see a swift turnaround in the company’s quarterly sales. This has resulted in the company now trading with a price-to-earnings ratio of 6.94 which is ludicrously cheap for a company with a market cap of around $100billion. Nevertheless, the question still remains whether the stock is going lower.

  • [By Cory Renauer]

    Get your popcorn and settle in for a biotechnology Clash of the Titans. In one corner stands Celgene Corporation (NASDAQ:CELG), an oncology powerhouse on the rise. In the other corner stands Gilead Sciences, Inc. (NASDAQ:GILD), an antiviral heavyweight that may be past its prime.

  • [By Spencer Israel]

    And these were the most popular sells:

    Bristol-Myers Squibb Co(NYSE: BMY)
    Pfizer Inc. (NYSE: PFE)
    Gilead Sciences, Inc. (NASDAQ: GILD)
    ConocoPhillips (NYSE: COP)
    Chevron Corporation (NYSE: CVX)
    The following chart shows the IMX performance since it's inception at the end of 2012. You can see how it's generally correlated to the broader equities market. 

  • [By Keith Speights]

    When John Milligan speaks, people listen — especially if they’re Gilead Sciences (NASDAQ:GILD) shareholders.

    The big biotech’s CEO and its CFO Robin Washington sat down to field questions at the RBC Capital Markets 2017 Healthcare Conference in New York City on Wednesday. Milligan spoke directly to some of the most pressing concerns for Gilead shareholders. Here are three things he said that you’ll definitely want to know.

stock market information: Federal-Mogul Holdings Corporation(FDML)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Mario Gabelli on Monday gained the upper hand in his battle to force Carl Icahn to sweeten his offer for a car-parts manufacturer. Icahn, who owns 82 percent of Federal-Mogul (NASDAQ: FDML), offered $9.25 a share for the remaining stake but fell way short after Gamco Investors boss Gabelli — who has a leading stake in Federal-Mogul — pressed for a higher price.

stock market information: Occidental Petroleum Corporation(OXY)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Stocks that made the cut include General Motors (GM), Coca-Cola Company (KO), Occidental Petroleum (OXY), JPMorgan Chase (JPM), and General Electric (GE).

  • [By Lee Jackson]

    These companies also reported insider buying last week: Carrizo Oil and Gas Inc. (NASDAQ: CRZO), Medifast Inc. (NYSE: MED), Medley Capital Corp. (NYSE: MCC), Occidental Petroleum Corp. (NYSE: OXY) and Sothebys (NYSE: BID).

  • [By Garrett Cook]

    Citi notes that presentations from producers (the bank specifically notes Anadarko (NYSE: APC), Occidental Petroleum (NYSE: OXY), and Pioneer Natural Resources (NYSE: PXD)) showed a lack of commitment to enter 2017 hedge programs to lock in the economics for drilling.

  • [By Paul Ausick]

    Occidental Petroleum Corp. (NYSE: OXY) dropped about 1.6% Friday, to post a new 52-week low of $64.19 after closing at $65.25 on Thursday. The stock’s 52-week high is $78.48. Volume was about 15% below the daily average of around 4.7 million shares. The company had no specific news.

  • [By Chris Lange]

    Occidental Petroleum Corp.s (NYSE: OXY) short interest increased to 16.11 million shares from the previous reading of 15.70 million. Shares were recently at $62.83, in a 52-week range of $61.01 to $78.48.

  • [By Ben Levisohn]

    We have seen several dividend cuts in the recent past, including Anadarko Petroleum cutting its dividend by 81%…and we expect more companies to follow suit. Chesapeake Energy (CHK), ConocoPhillips (COP), Encana,Marathon Oil and Noble Energy (NBL) are among energy companies that have also cut dividends in the past 12 months, but dividend requirements even after several cuts will consume ~26% of 2016 estimated cash flow at current dividend rates (15% excluding Occidental Petroleum (OXY)) for the large cap E&Ps we cover. We believe most of the companies with a dividend yield of more than 1.5% should consider cutting the dividend and find the following companies more likely than not to reduce dividends:Apache (2.5% yield),Devon Energy (4%),Encana (1.5%) andMarathon Oil (2.5%). We believe Canadian Natural Resource (CNQ) (3.0%) is likely to maintain its dividend while Occidental (4.5%) has the financial strength to maintain or even increase the dividend…

Top 5 Medical Stocks For 2018

Shutterstock

Read any newspaper in the world and you know there are challenges – refugee crises, cybersecurity threats, broken institutions, civil unrest, the list goes on.

Beneath the surface of these boiling problems lies a deeper challenge—to which many are unaware.  There is no established and secure digital identity system with a verifiable biometrics component for the 7.5 billion people living on Earth.

Who are you, and how do I know you are who you say you are?  What do you do when someone takes your identity?  How do I know this is your vote? How do I know that you are not a threat? How do I know that I can trust you?

For too many, a lack of verifiable identity means a lack of access – to a voice, to the world economy, to medical care, to mobility, to land.  In an increasingly digital world, according to the World Bank, there are more than 1.5 billion people who, for all practical purposes, do not exist. And for countless businesses, governments and institutions, this absence of a trusted identity system is an expensive and increasingly difficult predicament.

Top 5 Medical Stocks For 2018: Huaneng Power International, Inc.(HNP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, utilities shares rose by just 0.5 percent. Meanwhile, top losers in the sector included TransAlta Corporation (USA) (NYSE: TAC), down 1 percent, and Huaneng Power International Inc (ADR) (NYSE: HNP), down 1 percent.

Top 5 Medical Stocks For 2018: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

Top 5 Medical Stocks For 2018: Phillips 66(PSX)

Advisors’ Opinion:

  • [By Sarfaraz Khan]

    Also note that Berkshire Hathaway has direct exposure to the US energy sector through its subsidiary Berkshire Hathaway Energy, which is a power company that also owns two interstate natural gas pipelines. Besides, Berkshire Hathaways stock portfolio also has some exposure to the energy sector. The company owns 80.7 million shares of Phillips 66 (NYSE:PSX), a major US-based refiner that is also expanding in the midstream space, valued at almost $7 billion. Phillips 66 represents more than 5% of Berkshire Hathaways stock portfolio. The conglomerate also owns 20 million shares of the pipeline giant Kinder Morgan (NYSE:KMI), valued at $414.2 million. These energy companies are positioned to benefit from Donald Trumps pro-energy policies and de-regulation.

  • [By WWW.THESTREET.COM]

    “As a technician, I see largely rangebound motion with big bounces being retraced and fades being bought at deep support,” she added. “As the markets opened, holding over $48.12 will likely spell a bullish run as several refineries are closed in the region, such as Phillips66 (PSX) , Shell Petrobras and Exxon (XOM) . The support tests that hold $47.3 will be buy zones more than likely. Overall, the current remains the same – a largely landlocked region with only temporary moves up or down until the rebalancing looks better.”

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS).
    Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

Top 5 Medical Stocks For 2018: Toro Company (The)(TTC)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In his “Homework” segment, Cramer followed up on a few stocks that had stumped him during earlier shows. He said that he’s taking a pass on Toro (TTC) , a stock that’s just off its highs and trades at a premium to rival Deere & Company (DE) .

  • [By Mitchell Clark]

     The Toro Company (NYSE:TTC) is one of my favorite small-caps for medium- to long-term investors. Selling specialized equipment for turf management and other industries, Toro is a proven winner that has provided very consistent growth in sales and earnings over the years.

    It’s not the fastest growing small-cap business, but it pays a decent dividend and has a loyal customer base in the golf course and contractor markets.

    Toro is now offering sprinkler refit equipment for water-starved jurisdictions like California. This company’s share price performance has been exemplary.

Top 5 Medical Stocks For 2018: Allot Communications Ltd.(ALLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Telecommunications services shares gained around 0.98 percent in trading on Thursday. Meanwhile, top gainers in the sector included Telefonica S.A. (ADR) (NYSE: TEF), and Allot Communications Ltd (NASDAQ: ALLT).

technical analysis stocks

A privately-run detention center is exploiting immigrants by paying them a dollar a day, Washington State’s attorney general says.

Attorney General Bob Ferguson said Wednesday that he’s suing GEO Group (GEO), a private prison operator.

The suit alleges GEO Group uses immigration detainees to run “virtually all non-security functions” at its Northwest Detention Center (NWDC) in Tacoma, Washington — all while paying them next to nothing. Detainee responsibilities range from cooking and cleaning to painting.

“A multi-billion dollar corporation is trying to get away with paying its workers $1 per day,” Ferguson said in a statement. “That shouldn’t happen in America, and I will not tolerate it happening in Washington.”

The complaint also alleges GEO Group paid some workers even less by instead compensating them with “snack food such as chicken, potato chips, soda and/or candy.”

GEO Group said it “strongly refutes” Ferguson’s claims, calling them “baseless” and “meritless allegations.”

technical analysis stocks: Oxford Industries Inc.(OXM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Oxford Industries Inc (NYSE: OXM) was down, falling around 11 percent to $64.05. Oxford Industries reported a narrower-than-expected loss for its third quarter. The company projects full-year earnings of $3.50 to $3.65 per share, and revenue of $1.02 billion to $1.03 billion.

  • [By Ben Levisohn]

    Looking at recent historical deals, we arrive at a $18-$23 potential deal range. We analyzed transactions that have been announced over the past four years and involved companies catering to a higher income customer. These deals include Southern Tide (acquired by Oxford Industries (OXM)), Joe’s Jeans (acquired by Sequential Brands Group (SQBG)), prAna (acquired by Columbia Sportswear (COLM)), The Jones Group (acquired by Sycamore Partners [private] and Juicy Couture (acquired by Authentic Brands Group [private]). The average EV/EBITDA multiple of these transactions are 12.9x (in line with KATE’s 5-year historical average of 12.1x) and implies a potential deal range of $22-$23. When taking the average of recent (F13-16) deals implies an ~10.5x EV/EBITDA multiple. When applying the ~10.5x multiples to KATE’s trailing EBITDA, we arrive at an $18- $19 potential share price.

technical analysis stocks: Garmin Ltd.(GRMN)

Advisors’ Opinion:

  • [By Timothy Green]

    For dividend investors wanting a solid yield, Nordstrom (NYSE:JWN), International Business Machines (NYSE:IBM), and Garmin (NASDAQ:GRMN) look like solid choices. None is risk-free, particularly Nordstrom, which is in an extremely competitive industry. But all three offer dividend yields above 3% and a least a few reasons to be optimistic about the company.

  • [By Asit Sharma]

    Sometimes, in The Motley Fool’s “Better Buy” series, it’s not too difficult to identify the more attractive investment between two similar companies. In the matchup between health and fitness tracker leaderFitbit Inc. (NYSE:FIT) and GPS and wearables devices manufacturerGarmin Ltd. (NASDAQ:GRMN), the latter has a decisive edge, and I’ll briefly substantiate why below.However, if you happen to lean toward value situations or have a speculative bent, you may still be inclined to take a position in Fitbit, so in this article, we’ll also examine the contrarian case.

  • [By Leo Sun]

    However, investors shouldn’t completely ignore the growth potential of other wearable makers. Let’s take a closer look at three companies — Garmin (NASDAQ:GRMN), Taser International (NASDAQ:TASR), and Ambarella (NASDAQ:AMBA) — which could still benefit from high sales of wearable devices even as market leaders like Fitbit and GoPro struggle with sluggish growth.

  • [By WWW.THESTREET.COM]

    When it comes to personal electronics, market darling Fitbit (FIT) has clearly lost its mojo, while navigation giant Garmin (GRMN) has made a miraculous turnaround.

  • [By Teresa Rivas]

    Garmin (GRMN) climbed to the top of the S&P 500 Wednesday, thanks to its better-than-expected fourth quarter.

    Garmin rose $3.70, or 7.3%, to $54.15. By contrast, the S&P 500 lost2.56 points, or 0.11%, to 2362.82.

    Garmin said it earned 73 cents a share on revenue that rose 10.2% to $860.8 million. Analysts were looking for 58 cents per share in earnings or revenue of $794.8 million.

    For the full year, Garmin said it expects to earn$2.65 a share, matching analysts’ estimates.

    Piper Jaffray’s William Power liked the quarter, but reiterated a Neutral rating on the stock. From his note:

    Outdoor revenue of $175.4 million handily beat our $139.1 million estimate, driven in part by initial fenix 5 sales.Fitness revenue of $274.1 million beat our $263.1 million estimate and grew 19.8% YOY, driven by wearables with heart rate and wearables for children.Aviation and marine revenue of $117.3 million and $67.5 million, also beat our $105.1 million and $59.3 million estimates, and grew 12.7% and 19.5% YOY, respectively.

    Garmin shares are up 11.7% year to date.

technical analysis stocks: Navistar International Corporation(NAV)

Advisors’ Opinion:

  • [By Lee Jackson]

    Icahn also was a buyer last week of Navistar International Corp. (NYSE: NAV). He acquireda total of 423.404 shares of the truck and engine maker at prices that ranged from $25.37 to $25.92. The total for the buy was listed at $11 million. The stock closed Friday at $27.49, so it looks like another well-timed buy. The 52-week range for the shares is $10.30 to $33.46, and the consensus price target is $26.79.

  • [By Lee Jackson]

    Navistar International Corp. (NYSE: NAV) was started with a Buy rating and a $36 price objective at Aegis Capital. That compares with a consensus target of $24.08. The 52-week range is $5.78 to $32.84. The stock closed yesterday at $30.93.

technical analysis stocks: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

technical analysis stocks: Telefonica Brasil S.A.(VIV)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, telecommunications services shares slipped by 0.08 percent. Meanwhile, top losers in the sector included Turkcell Iletisim Hizmetleri A.S. (ADR) (NYSE: TKC), down 2 percent, and Telefonica Brasil SA (ADR) (NYSE: VIV), down 2.5 percent.

  • [By Sofia Horta e Costa]

    Vivendi (VIV) rose 2.7 percent to 17.15 euros. Music, pay-TV, European cinema and Internet in Brazil will make up a new media group based in France after the split with phone unit SFR, according to a statement yesterday.

Top 10 Bank Stocks To Own Right Now

It’s official: Your browsing history can be sold to advertisers. President Trump on Monday signed a measure reversing rules that would have required internet providers to get consent before selling your browsing history.

The rules had not yet gone into effect, but providers now find themselves with new freedom when it comes to collecting and selling their customers’ data. What does that mean for you?

What identifying information do they have?

Internet providers already collect a lot of information that’s necessary to maintain their networks, like your location and what you’re looking at online.

Many have said they will not use “sensitive” information, like medical records, children’s data and banking details without consent. However a simple browsing history can reveal those personal details, such as symptoms you’ve Googled. There are concerns that it would be possible to identify people based on this detailed information.

According to Dane Jasper, cofounder of Sonic, an independent ISP located in California, an internet provider can infer a lot about you based just on your browsing. In addition to basics like age and gender, they might know who your friends are, if you’re a recovering alcoholic, or where you went to school. In theory, they could create an in-depth profile of you.

Top 10 Bank Stocks To Own Right Now: Terra Nitrogen Company L.P.(TNH)

Advisors’ Opinion:

  • [By Robert Rapier] While the MLP space is dominated by the oil and gas sector, in last week’s article we began to explore some of the more exotic master limited partnership offerings. This week we continue our exploration of nontraditional MLPs by looking at the partnerships supplying fertilizer.

    Rentech (Nasdaq: RTK) has been around for more than a decade, and it has shifted strategies several times. Full disclosure: Rentech’s Chief Technology Officer Harold Wright is a former manager of mine when we were both at ConocoPhillips, and I have visited Rentech’s facility in Commerce City, Colorado.

    For most of Rentech’s existence, the company has sought to commercialize alternative fuels. At one time it had ambitions to build a large coal-to-liquids (CTL) plant, but federal legislation ultimately nudged it instead into the biomass-to-liquids (BTL) space. The company did build a BTL demonstration plant, but ultimately shut it down and has now refocused its efforts on becoming “one of the largest wood processing companies in the world.”

    During its interesting journey as a company, Rentech acquired two ammonia nitrogen fertilizer facilities, which turned out to be a profit center that funded the alternative energy research. In November 2011, Rentech spun off this fertilizer business into an MLP called Rentech Nitrogen Partners LP (NYSE: RNF).

    In the months leading to the spin-off, RTK’s market capitalization was about $200 million. Rentech maintained 60 percent ownership of RNF, and three months after the spin-off RTK’s market cap had risen to $400 million, while investors had bid RNF up to $1 billion. Interestingly, RTK’s share of RNF was worth more than RTK’s entire market cap, a situation that persists. The market currently values Rentech at $482 million, while the valuation of Rentech Nitrogen Partners makes RTK’s 60 percent stake in RNF worth slightly more than $600 million — another illu

Top 10 Bank Stocks To Own Right Now: Mechel OAO(MTL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Basic materials shares climbed by 2.37 percent in trading on Wednesday. Meanwhile, top gainers in the sector included Handy & Harman Ltd (NYSE: HNH), and Mechel PAO (ADR) (NYSE: MTL).

  • [By Lisa Levin]

    Tuesday morning, the basic materials shares climbed by 0.95 percent. Meanwhile, top gainers in the sector included Allegheny Technologies Incorporated (NYSE: ATI), up 5 percent, and Mechel PAO (ADR) (NYSE: MTL), up 5 percent.

  • [By Shanthi Rexaline]

    Mechel PAO (ADR) (NYSE: MTL) is rallying strongly, rising to a three-year high on roughly 1.7 times its average volume.

    The stock has been on a tear in recent months. After dipping below the $2 level in late April and languishing in the sub-$2 range until August, the stock has nearly tripled in the run up to Monday’s session.

Top 10 Bank Stocks To Own Right Now: Aurinia Pharmaceuticals Inc(AUPH)

Advisors’ Opinion:

  • [By Todd Campbell]

    After positive mid-stage trial data suggested earlier this year that it might be able to reshape the treatment of kidney failure in lupus patients, Aurinia Pharmaceuticals (NASDAQ:AUPH)has announced plans for a late-stage study that could eventually allow it to win regulatory OKs in the U.S., Europe, and Japan.

  • [By Lisa Levin] Related NVCN 18 Biggest Mid-Day Losers For Wednesday Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data Boston Scientific closes Neovasc transaction (Seeking Alpha)
    Related BSX Watch These 10 Huge Call Purchases In Monday Trade Wonderful Wearables Get Their Own ETF Boston Scientific closes Neovasc transaction (Seeking Alpha) Gainers
    Neovasc Inc (US) (NASDAQ: NVCN) rose 17.3 percent to $2.65 in pre-market trading after the company reported the close of its $75 million transaction with Boston Scientific Corporation (NYSE: BSX).
    aTyr Pharma Inc (NASDAQ: LIFE) shares rose 12.3 percent to $4.10 in pre-market trading after the company disclosed 'promising' signals in myopathies with Resolaris in exploratory trials.
    Globus Maritime Ltd (NASDAQ: GLBS) shares rose 10.1 percent to $6.90 in pre-market trading after climbing 5.03 percent on Monday.
    Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares rose 9.9 percent to $3.00 in pre-market trading. Aurinia Pharmaceuticals appointed Lorin Jeffry “Jeff” Randall to its board and Chairman of the Audit Committee.
    Ocean Rig UDW Inc. (NASDAQ: ORIG) shares rose 8.7 percent to $2.89 in pre-market trading after surging 19.82 percent on Monday.
    Full House Resorts, Inc. (NASDAQ: FLL) shares rose 5.1 percent to $2.08 in pre-market trading after declining 1.98 percent on Monday.
    Seadrill Ltd (NYSE: SDRL) rose 5.1 percent to $4.13 in pre-market trading after surging 3.15 percent on Monday.
    Noble Corporation (NYSE: NE) rose 5.1 percent to $7.60 in pre-market trading after declining 5.37 percent on Monday.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 5.1 percent to $3.10 in pre-market trading. Arbutus issued additional data from its ARB-1467 Phase II
  • [By Lisa Levin]

    Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares shot up 24 percent to $4.60 after the company disclosed that Voclosporin met 48-week remission endpoints.

Top 10 Bank Stocks To Own Right Now: Vitality Biopharma (VBIO)

Advisors’ Opinion:

  • [By James E. Brumley]

    Investors who were looking to learn a little more about up-and-coming drug development company Vitality Biopharma Inc (OTCMKTS:VBIO) may want to mark December 8th on their calendar…. if they’re going to be in the Los Angeles area that day anyway. The company will be making a presentation that day, at the annual LD Micro Main Event. Interested and approved investors can attend the VBIO presentation by registering beforehand with LD Micro.

    Vitality Biopharma has found a way to make cannabinoid-based pharmaceuticals without the usual downside of cannabinoids. Namely, Vitality Biopharma’s version of cannabinoids are non-psychotropic, meaning larger, more effective dosing is possible without the ‘high’. It’s this little detail that takes cannabinoid medicine — already the most compelling frontier in the world of pharma — to the next level. There’s a reason some people think the cannabinoid market could be worth $20 billion by 2020.

    The idea was significantly advanced in early November. In eight of the nine states voters were asked about legalization of marijuana (for one reason or another), voters said yes….. four for recreational use, and four for medical use. In eight of those nine states, the measures passed. Marijuana is legal in more than half the United States now, and we’re en route to a decided majority in the foreseeable future.

    VBIO didn’t necessarily need a sweeping victory at the ballot box, but each time marijuana wins, it seems to advance the discussion of the power of cannabinoids as medicine.

    Investors will be able to learn more about Vitality Biopharma’s work in that arena on Thursday of this week. On that day — 8 AM PST / 11 AM EST — at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Robert Brooke, CEO of Vitality Biopharma, will be making a presentation as well as meeting with current and prospective investors.

    LD Micro was founded in 2006 with the sole purpose of being an independent resource in t

  • [By Matthew Briar]

    Back in September, Vitality Biopharma Inc (OTCMKTS:VBIO) CEO Robert Brooke officially announced his company would be entering the painkiller market, specifically taking aim at the development of an alternative to opioids. His specific words? “Opiates are one of the key classes of drugs we’re seeking to replace, or to make far less necessary, as our proprietary cannabosides could provide a potent alternative form of pain relief and help avoid, or greatly reduce, the use of opiates for the treatment of many conditions…”

  • [By Phil Saunders]

    Vitality Biopharma, Inc. (OTCBB: VBIO) recent ascent as a strong small cap player in Cannabis pharma, is part of a boom in Cannabis-based pharmaceuticals making announcements about unique and innovative delivery systems being tested for such ailments as Epilepsy, Multiple Sclerosis, and Crohns disease. But it is important to understand how the industry is evolving in the United States and Canada and what that might mean when realizing valuation and the evolution of government policies which still vary from jurisdiction to jurisdiction, making access to Cannabis and the pricing model still a big question moving forward.

  • [By James E. Brumley]

    Are you an investor interested in learning more about Vitality Biopharma Inc (OTCMKTS:VBIO)? Or, are you looking to take your first look at VBIO? A SeeThruEquity research report posted in August not only has you covered, it underscores all of its hidden bullishness. The report also explains a very impressive target price for Vitality Biopharma shares. In short, the research outfit now believes the stock will see $2.00 per share sooner than later, based on its pipeline and potential market penetration. That’s 38% higher than its current value.

  • [By Jim Robertson]

    That’s why its worth pointing out that just yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announced the appointment of Tracy Rockney, J.D. to the position of Senior Regulatory Advisor. In addition to being the Co-Founder & Chief Operating Officer of OneSource Regulatory, a regulatory consulting firm, Rockney was previously:

  • [By James E. Brumley]

    In mid-September, Vitality Biopharma Inc (OTCMKTS:VBIO) announced it was going to take aim at the development of an alternative to opioids as a means of treating pain. At the time, there was little doubt that the company’s cannabinoid science was capable of doing so. What wasn’t clear to VBIO shareholders was exactly how that might happen…. meaning what sort of drug might Vitality Biopharma come up with.

    We got the first of what will likely be several answers to the question today. Per today’s press release, Vitality Biopharma intends to come up with a treatment for narcotic bowel syndrome, which is a severe form of (ironically enough) opiate-induced abdominal pain.

    As a refresher, Vitality Biopharma was the name we introduced to you back on August 8th, pointing out it had developed a whole new way of making cannabinoid-based medicines. Their versions offer all the upsides of cannabinoids, but without the psychotropic (“getting high’) effects, and without some of the common downsides associated with these pharmaceuticals… like mouth and skin lesions.

    There are even bigger advantages to Vitality Biopharma’s science, however. Namely, since these drugs are prodrugs and aren’t activated until in the body, they allow for targeted delivery to the GI tract (yet can also selectively target other body parts, even as far away from the GI tract as the brain). Perhaps more than anything though, these drugs are orally-administered by virtue of being highly soluble, making them easy to use.

    It’s this nuance that makes Vitality Biopharma’s recently-announced intention so interesting, and compelling.

    Studies have found that up to 81% of patients treated with opiates have functional bowel disorders, with more than half — 58% to be exact — of opiate users reporting chronic abdominal pain stemming from the use of their prescribed painkillers. Considering 200 million opioid prescriptions are filled every year in the United States alo

Top 10 Bank Stocks To Own Right Now: Celestica, Inc.(CLS)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of mid caps Jabil Circuit and Flextronics International Ltd (NASDAQ: FLEX) along with small capCelestica Inc (NYSE: CLS) and Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newslettersuggestion as the next breakout stock, all performing well recently as the tech stocks they supply outperform:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newsletter suggestion as the next breakout stock, andmid cap Flextronics International being bigger winners compared with the also good performance of mid cap Jabil Circuit, Inc (NYSE: JBL) and small cap Celestica Inc (NYSE: CLS):

Top 10 Bank Stocks To Own Right Now: First NBC Bank Holding Company(FNBC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

  • [By Lisa Levin]

    First NBC Bank Holding Company (NASDAQ: FNBC) shares dropped 91 percent to $0.250. First NBC Bank was closed by the Louisiana Office of Financial Institutions.

Top 10 Bank Stocks To Own Right Now: Media General, Inc.(MEG)

Advisors’ Opinion:

  • [By Monica Gerson]

    Media General Inc (NYSE: MEG) is estimated to report its quarterly earnings at $0.04 per share on revenue of $340.17 million.

    National Health Investors Inc (NYSE: NHI) is expected to post its quarterly earnings at $1.17 per share on revenue of $57.82 million.

Top 10 Bank Stocks To Own Right Now: Ebix, Inc.(EBIX)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap insurance software stock Ebix Inc (NASDAQ: EBIX) reported Q1 2017 earnings before the market opened this morning. Q1 revenue rose 11% to $79.1 million and decreased 1% over Q4 2016 revenue of $80.0 million. The year over year revenue improvement reflected growth in the Companys Exchange, Risk Compliance, and Broker Solution channels. On a constant currency basis, Q1 revenue increased 10% to $78.5 millionwith theExchange channel continued to bethe Companyslargest -accounting for 67% of Q1 2017 revenues. Q1 2017 net income rose 19% to $26.4 million with the improvement principally reflected the benefit of higher revenues and operating income as compared to the same period last year.

Top 10 Bank Stocks To Own Right Now: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

Top 10 Bank Stocks To Own Right Now: Virtus Investment Partners Inc.(VRTS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Virtus Investment Partners Inc (NASDAQ: VRTS) got a boost, shooting up 19 percent to $111.05 following Q3 results. Virtus Investment posted Q3 earnings of $1.64 per share on revenue of $82.3 million.

free penny stock picks

By Kevyn Burger, Next Avenue Contributor

Born on the Pine Ridge Indian Reservation in South Dakota, Kathy Janis was taught to revere the elders in her Oglala Sioux Tribe.

Oglala Sioux Lakota Nursing Home

Oglala Sioux Lakota Nursing Home Activities Director Jacque Knight, resident Bernadine Elk Boy and CNA April Two Bulls

I was raised to consider every one of them to be a relative. Respect is instilled in us, she said. My parents didnt tell it, they lived it and showed us.

Thats why Janis prioritized the needs of her older relatives while serving on the Tribal Council. More than a decade ago, the governing body began laying the groundwork to build a nursing home specifically for the tribes members. An early step was visiting tribal elders who were scattered in facilities around the country to see if they would be interested in a nursing home on tribal land.

free penny stock picks: ZTE Corporation (ZTCOF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Chinese telco equipment giant ZTE (OTCPK:ZTCOF) has been actively cooperating and communicating with relevant U.S. government departments in order to reach a conclusion of the investigation related to the compny’s violations of sanctions on Iran.

  • [By SEEKINGALPHA.COM]

    The United States has a history of preventing Chinese companies that are even suspected of being state-owned from selling certain products into key industries. Huawei and ZTE (OTCPK:ZTCOF), for example, were under harsh scrutiny for their telecommunications equipment.

free penny stock picks: Emerson Electric Company(EMR)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Industrial companies like Dover (DOV), Emerson Electric (EMR), Eaton (ETN), 3M (MMM) and Rockwell Automation (ROK) are calling for earnings growth to get better during the second half of the year. Bernstein’s Steven Winoker and team aren’t feeling as confident:

  • [By Lisa Levin]

    Breaking news

    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected profit for its first quarter on Wednesday.
    Helmerich & Payne, Inc. (NYSE: HP) posted upbeat results for its fourth quarter.
    NetApp Inc. (NASDAQ: NTAP) reported stronger-than-expected results for its second quarter and issued strong Q3 guidance.
    Emerson Electric Co. (NYSE: EMR) proposed to acquire Rockwell Automation (NYSE: ROK) for $225 per share in cash and stock.

  • [By Ben Levisohn]

    Lower WACC has moved in lockstep with higher multiples and as the rate regime shifts, we see limited excuses for another leg absent material growth. EPS growth/visibility at a reasonable price will matter, with those that are not reflecting upside today seeing multiple expansion and safety stocks that are not safe reverting. With this backdrop, our top picks are Honeywell, Ingersoll-Rand, and Danaher, with a positive bias on Neutral-rated United Technologies, while we are most negative onGeneral Electric and Rockwell Automation (ROK), with a negative bias on N-rated $51.92 Emerson Electric (EMR)…

  • [By Ben Levisohn]

    3) Other downside catalysts have come and gone, such asEmerson Electric (EMR) effectively ruling out aRockwell deal;

    4) However, our view that the upward trajectory in customer capex spending remains muted combined with the stock still trading at >19x NTM EPS limits our upgrade to just Market-Perform despite our long-term bullish view of industrial automation in general and Rockwell specifically

  • [By Ben Levisohn]

    Shares of General Electric have dropped 3.8% so far this year, with everything from its accounting to weaker margins being blamed for its weakness. Barclays’ Scott Davis and team, however, spoke with a source they call the “smartest man in the room,” who just so happens to be “nibbling” on General Electric now. They explain why and offer his views on Honeywell International (HON), Emerson Electric (EMR), and ITT (ITT) as well:

free penny stock picks: Kronos Worldwide Inc(KRO)

Advisors’ Opinion:

  • [By Monica Gerson]

    Kronos Worldwide, Inc. (NYSE: KRO) is projected to post a quarterly loss at $0.13 per share on revenue of $308.50 million.

    Energen Corporation (NYSE: EGN) is estimated to post a quarterly loss at $0.67 per share on revenue of $122.91 million.

free penny stock picks: Liberty Interactive Corporation(QVCA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    QVC (QVCA) was upgraded to buy from neutral at Bank of America/Merrill Lynch. $25 price target. The company can turn its sales around and deserves a higher multiple, analysts said. 

free penny stock picks: FMC Technologies, Inc.(FTI)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Following a series of M&A announcements in the oilfield-services sector since the onset of the oil market downturn, French oil-field service company Technip and U.S. oilfield equipment company FMC Technologies (NYSE:FTI) hooked up in an all-stock deal valuing the combined company at $13 billion. Shareholders of each company will own 50% of the combined entity, to be named TechnipFMC, which implies a roughly $6.5 billion acquisition valuation for each entity. The transaction, which should close early next year, will “combine Technip’s innovative systems and solutions, state-of-the-art assets, engineering strengths, and project management capabilities with FMC Technologies’ leading technology, manufacturing, and service capabilities.” Further, it should save $400 million in annual costs by 2019. Moreover, it will enable the combined company to compete better against larger oil-field service rivals Baker Hughes (NYSE:BHI), Halliburton (NYSE:HAL), and Schlumberger (NYSE:SLB), which have all gained strength during the downturn either through M&A activities or cost savings initiatives.

free penny stock picks: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.